Disposable Syringes Market by Product type (Conventional Disposable Syringesand Safety Disposable Syringes) and Application (Immunization Injectionsand Therapeutic Injections), Global Opportunity Analysis and Industry Forecast, 2019–2026
The global disposable syringes market accounted for $5,450 million in 2018, and is expected to reach $8,113.7 million by 2026, registering a CAGR of 5.1% from 2019 to 2026.
Disposable syringes are medical devices which are employed in one time administration of therapeutic agents to the body of a patient. Furthermore, these devices are also used in extraction of blood samples from the body of patients which are then analyzed to diagnose a medical condition. In addition, disposable syringes are also employed in administration of weakened strains of viruses to build immunity against them. Moreover, syringes draw out blood and administer drugs by the aid of a piston mechanism. There are different type of syringes present in market which offer different advantages. For instance, safety disposable syringes offer protection against needle stick injuries.
The major factor that contributes to the growth of disposable syringes market include surge in the use of injectable drugs, due to the lack of bioavailability in conventional drug delivery methods. Furthermore, other factors such as rise in healthcare expenditure and surge in cases of needlestick injuries also fuel the growth of disposable syringes market. In addition, surge in the prevalence of various chronic diseases which require the use of disposable syringes systems is another major factor that contributes to the growth of market. However, high cost of disposable safety disposable syringes restricts the growth of disposable syringes market. Conversely, high growth potential in developing economies is expected to offer lucrative opportunities during the forecast period.
The disposable syringes market size is studied on the basis of product type, application, and region to provide a detailed assessment of the market. On the basis of product type, it is segmented into conventional disposable syringes, and safety disposable syringes. By application, it is bifurcated into immunization injections, and therapeutic injections. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
Disposable syringes are medical devices which are employed in one time administration of therapeutic agents to the body of a patient. Furthermore, these devices are also used in extraction of blood samples from the body of patients which are then analyzed to diagnose a medical condition. In addition, disposable syringes are also employed in administration of weakened strains of viruses to build immunity against them. Moreover, syringes draw out blood and administer drugs by the aid of a piston mechanism. There are different type of syringes present in market which offer different advantages. For instance, safety disposable syringes offer protection against needle stick injuries.
The major factor that contributes to the growth of disposable syringes market include surge in the use of injectable drugs, due to the lack of bioavailability in conventional drug delivery methods. Furthermore, other factors such as rise in healthcare expenditure and surge in cases of needlestick injuries also fuel the growth of disposable syringes market. In addition, surge in the prevalence of various chronic diseases which require the use of disposable syringes systems is another major factor that contributes to the growth of market. However, high cost of disposable safety disposable syringes restricts the growth of disposable syringes market. Conversely, high growth potential in developing economies is expected to offer lucrative opportunities during the forecast period.
The disposable syringes market size is studied on the basis of product type, application, and region to provide a detailed assessment of the market. On the basis of product type, it is segmented into conventional disposable syringes, and safety disposable syringes. By application, it is bifurcated into immunization injections, and therapeutic injections. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
- This report entails a detailed quantitative analysis along with the current global disposable syringes market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessments.
- The market size and estimations are based on a comprehensive analysis of key developments in the industry.
- A qualitative analysis based on innovative products facilitates strategic business planning.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
- By Product type
- Conventional disposable syringes
- Safety disposable syringes
- By Application
- Immunization Injections
- Therapeutic Injections
- By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Baxter International Inc.
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Cardinal Health
- Henke-Sass Wolf
- Nipro Medical Corporation
- Novo Nordisk A/S
- Retractable Technologies, Inc.
- Terumo Corporation
- Vita Needle Company.
- Star Syringe Ltd.
- Smiths Medical
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.2.1.List of key players profiled in the report
1.3.Research methodology
1.3.1.Primary research
1.3.2.Secondary research
1.3.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Top player positioning
3.2.1.Top investment pockets
3.3.Key forces shaping disposable syringes industry/market
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Rise in prevalence of needlestick injuries
3.4.1.2.Surge in healthcare expenditure worldwide
3.4.1.3.Favorable government initiatives
3.4.1.4.Increase in prevalence of chronic conditions and infectious diseases
3.4.2.Restraints
3.4.2.1.High cost of safety disposable syringes
3.4.2.2.Availability of alternative modes of delivery
3.4.3.Opportunity
3.4.3.1.High growth potential in developing economies
3.4.4.Impact Analysis
CHAPTER 4:DISPOSABLE SYRINGES MARKET, BY PRODUCT TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Conventional Disposable Syringes
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Safety Disposable Syringes
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
CHAPTER 5:DISPOSABLE SYRINGES MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Immunization Injections
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Therapeutic Injections
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
CHAPTER 6:DISPOSABLE SYRINGES MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends and opportunities
6.2.2.Market analysis, by country
6.2.2.1.U.S.
6.2.2.1.1.U.S. market size and forecast, by product type
6.2.2.1.2.U.S. market size and forecast, by application
6.2.2.2.Canada
6.2.2.2.1.Canada market size and forecast, by product type
6.2.2.2.2.Canada market size and forecast, by application
6.2.2.3.Mexico
6.2.2.3.1.Mexico market size and forecast, by product type
6.2.2.3.2.Mexico market size and forecast, by application
6.2.3.North America market size and forecast, by product type
6.2.4.North America market size and forecast, by application
6.3.Europe
6.3.1.Key market trends and opportunities
6.3.2.Market analysis, by country
6.3.2.1.Germany
6.3.2.1.1.Germany market size and forecast, by product type
6.3.2.1.2.Germany market size and forecast, by application
6.3.2.2.France
6.3.2.2.1.France market size and forecast, by product type
6.3.2.2.2.France market size and forecast, by application
6.3.2.3.UK
6.3.2.3.1.UK market size and forecast, by product type
6.3.2.3.2.UK market size and forecast, by application
6.3.2.4.Italy
6.3.2.4.1.Italy market size and forecast, by product type
6.3.2.4.2.Italy market size and forecast, by application
6.3.2.5.Rest of Europe
6.3.2.5.1.Rest of Europe market size and forecast, by product type
6.3.2.5.2.Rest of Europe market size and forecast, by application
6.3.3.Europe market size and forecast, by product type
6.3.4.Europe market size and forecast, by application
6.4.Asia-Pacific
6.4.1.Key market trends and opportunities
6.4.2.Market analysis, by country
6.4.2.1.Japan
6.4.2.1.1.Japan market size and forecast, by product type
6.4.2.1.2.Japan market size and forecast, by application
6.4.2.2.China
6.4.2.2.1.China market size and forecast, by product type
6.4.2.2.2.China market size and forecast, by application
6.4.2.3.India
6.4.2.3.1.India market size and forecast, by product type
6.4.2.3.2.India market size and forecast, by application
6.4.2.4.Rest of Asia-Pacific
6.4.2.4.1.Rest of Asia-Pacific market size and forecast, by product type
6.4.2.4.2.Rest of Asia-Pacific market size and forecast, by application
6.4.3.Asia-Pacific market size and forecast, by product type
6.4.4.Asia-Pacific market size and forecast, by application
6.5.LAMEA
6.5.1.Key market trends and opportunities
6.5.2.Market analysis, by country
6.5.2.1.Brazil
6.5.2.1.1.Brazil market size and forecast, by product type
6.5.2.1.2.Brazil market size and forecast, by application
6.5.2.2.South Africa
6.5.2.2.1.South Africa market size and forecast, by product type
6.5.2.2.2.South Africa market size and forecast, by application
6.5.2.3.Saudi Arabia
6.5.2.3.1.Saudi Arabia market size and forecast, by product type
6.5.2.3.2.Saudi Arabia market size and forecast, by application
6.5.2.4.Rest of LAMEA
6.5.2.4.1.Rest of LAMEA market size and forecast, by product type
6.5.2.4.2.Rest of LAMEA market size and forecast, by application
6.5.3.LAMEA market size and forecast, by product type
6.5.4.LAMEA market size and forecast, by application
CHAPTER 7:COMPANY PROFILES
7.1.BAXTER INTERNATIONAL INC.
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.2.B. BRAUN MELSUNGEN AG
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.2.1.Key strategic moves and developments
7.3.BECTON, DICKINSON AND COMPANY
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments
7.4.CARDINAL HEALTH
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.5.HENKE-SASS WOLF
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.6.NIPRO MEDICAL CORPORATION
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.7.NOVO NORDISK A/S
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance
7.8.RETRACTABLE TECHNOLOGIES, INC.
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Business performance
7.9.TERUMO CORPORATION
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.9.6.Key strategic moves and developments
7.10.VITA NEEDLE COMPANY
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
1.1.Report description
1.2.Key market segments
1.2.1.List of key players profiled in the report
1.3.Research methodology
1.3.1.Primary research
1.3.2.Secondary research
1.3.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Top player positioning
3.2.1.Top investment pockets
3.3.Key forces shaping disposable syringes industry/market
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Rise in prevalence of needlestick injuries
3.4.1.2.Surge in healthcare expenditure worldwide
3.4.1.3.Favorable government initiatives
3.4.1.4.Increase in prevalence of chronic conditions and infectious diseases
3.4.2.Restraints
3.4.2.1.High cost of safety disposable syringes
3.4.2.2.Availability of alternative modes of delivery
3.4.3.Opportunity
3.4.3.1.High growth potential in developing economies
3.4.4.Impact Analysis
CHAPTER 4:DISPOSABLE SYRINGES MARKET, BY PRODUCT TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Conventional Disposable Syringes
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Safety Disposable Syringes
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
CHAPTER 5:DISPOSABLE SYRINGES MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Immunization Injections
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Therapeutic Injections
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
CHAPTER 6:DISPOSABLE SYRINGES MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends and opportunities
6.2.2.Market analysis, by country
6.2.2.1.U.S.
6.2.2.1.1.U.S. market size and forecast, by product type
6.2.2.1.2.U.S. market size and forecast, by application
6.2.2.2.Canada
6.2.2.2.1.Canada market size and forecast, by product type
6.2.2.2.2.Canada market size and forecast, by application
6.2.2.3.Mexico
6.2.2.3.1.Mexico market size and forecast, by product type
6.2.2.3.2.Mexico market size and forecast, by application
6.2.3.North America market size and forecast, by product type
6.2.4.North America market size and forecast, by application
6.3.Europe
6.3.1.Key market trends and opportunities
6.3.2.Market analysis, by country
6.3.2.1.Germany
6.3.2.1.1.Germany market size and forecast, by product type
6.3.2.1.2.Germany market size and forecast, by application
6.3.2.2.France
6.3.2.2.1.France market size and forecast, by product type
6.3.2.2.2.France market size and forecast, by application
6.3.2.3.UK
6.3.2.3.1.UK market size and forecast, by product type
6.3.2.3.2.UK market size and forecast, by application
6.3.2.4.Italy
6.3.2.4.1.Italy market size and forecast, by product type
6.3.2.4.2.Italy market size and forecast, by application
6.3.2.5.Rest of Europe
6.3.2.5.1.Rest of Europe market size and forecast, by product type
6.3.2.5.2.Rest of Europe market size and forecast, by application
6.3.3.Europe market size and forecast, by product type
6.3.4.Europe market size and forecast, by application
6.4.Asia-Pacific
6.4.1.Key market trends and opportunities
6.4.2.Market analysis, by country
6.4.2.1.Japan
6.4.2.1.1.Japan market size and forecast, by product type
6.4.2.1.2.Japan market size and forecast, by application
6.4.2.2.China
6.4.2.2.1.China market size and forecast, by product type
6.4.2.2.2.China market size and forecast, by application
6.4.2.3.India
6.4.2.3.1.India market size and forecast, by product type
6.4.2.3.2.India market size and forecast, by application
6.4.2.4.Rest of Asia-Pacific
6.4.2.4.1.Rest of Asia-Pacific market size and forecast, by product type
6.4.2.4.2.Rest of Asia-Pacific market size and forecast, by application
6.4.3.Asia-Pacific market size and forecast, by product type
6.4.4.Asia-Pacific market size and forecast, by application
6.5.LAMEA
6.5.1.Key market trends and opportunities
6.5.2.Market analysis, by country
6.5.2.1.Brazil
6.5.2.1.1.Brazil market size and forecast, by product type
6.5.2.1.2.Brazil market size and forecast, by application
6.5.2.2.South Africa
6.5.2.2.1.South Africa market size and forecast, by product type
6.5.2.2.2.South Africa market size and forecast, by application
6.5.2.3.Saudi Arabia
6.5.2.3.1.Saudi Arabia market size and forecast, by product type
6.5.2.3.2.Saudi Arabia market size and forecast, by application
6.5.2.4.Rest of LAMEA
6.5.2.4.1.Rest of LAMEA market size and forecast, by product type
6.5.2.4.2.Rest of LAMEA market size and forecast, by application
6.5.3.LAMEA market size and forecast, by product type
6.5.4.LAMEA market size and forecast, by application
CHAPTER 7:COMPANY PROFILES
7.1.BAXTER INTERNATIONAL INC.
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.2.B. BRAUN MELSUNGEN AG
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.2.1.Key strategic moves and developments
7.3.BECTON, DICKINSON AND COMPANY
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments
7.4.CARDINAL HEALTH
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.5.HENKE-SASS WOLF
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.6.NIPRO MEDICAL CORPORATION
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.7.NOVO NORDISK A/S
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance
7.8.RETRACTABLE TECHNOLOGIES, INC.
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Business performance
7.9.TERUMO CORPORATION
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.9.6.Key strategic moves and developments
7.10.VITA NEEDLE COMPANY
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
LIST OF TABLES
TABLE 01.GLOBAL DISPOSABLE SYRINGES MARKET, BY PRODUCT TYPE, 2018-2026 ($MILLION )
TABLE 02.CONVENTIONAL DISPOSABLE SYRINGES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 03.SAFETY DISPOSABLE SYRINGES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 04.GLOBAL DISPOSABLE SYRINGES MARKET, BY APPLICATION, 2018-2026 ($MILLION )
TABLE 05.DISPOSABLE SYRINGES MARKET FOR IMMUNIZATION INJECTIONS, BY REGION, 2018–2026 ($MILLION)
TABLE 06.DISPOSABLE SYRINGES MARKET FOR THERAPEUTIC INJECTIONS, BY REGION, 2018–2026 ($MILLION)
TABLE 07.DISPOSABLE SYRINGES MARKET, BY REGION, 2018-2026 ($MILLION )
TABLE 08.NORTH AMERICA DISPOSABLE SYRINGES MARKET REVENUE, BY COUNTRY, 2019–2026 ($MILLION)
TABLE 09.U.S. DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 10.U.S. DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 11.CANADA DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 12.CANADA DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 13.MEXICO DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 14.MEXICO DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 15.NORTH AMERICA DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026($MILLION)
TABLE 16.NORTH AMERICA DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 17.EUROPE DISPOSABLE SYRINGES MARKET REVENUE, BY COUNTRY, 2019–2026 ($MILLION)
TABLE 18.GERMANY DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 19.GERMANY DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 20.FRANCE DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 21.FRANCE DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 22.UK DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 23.UK DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 24.ITALY DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 25.ITALY DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 26.REST OF EUROPE DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 27.REST OF EUROPE DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 28.EUROPE DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026($MILLION)
TABLE 29.EUROPE DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 30.ASIA-PACIFIC DISPOSABLE SYRINGES MARKET REVENUE, BY COUNTRY, 2019–2026 ($MILLION)
TABLE 31.JAPAN DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 32.JAPAN DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 33.CHINA DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 34.CHINA DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 35.INDIA DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 36.INDIA DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 37.REST OF ASIA-PACIFIC DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 38.REST OF ASIA-PACIFIC DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 39.ASIA-PACIFIC DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026($MILLION)
TABLE 40.ASIA-PACIFIC DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 41.LAMEA DISPOSABLE SYRINGES MARKET REVENUE, BY COUNTRY, 2019–2026 ($MILLION)
TABLE 42.BRAZIL DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 43.BRAZIL DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 44.SOUTH AFRICA DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 45.SOUTH AFRICA DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 46.SAUDI ARABIA DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 47.SAUDI ARABIA DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 48.REST OF LAMEA DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 49.REST OF LAMEA DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 50.LAMEA DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026($MILLION)
TABLE 51.LAMEA DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 52.BAXTER: COMPANY SNAPSHOT
TABLE 53.BAXTER: OPERATING SEGMENTS
TABLE 54.BAXTER: PRODUCT PORTFOLIO
TABLE 55.B. BRAUN.: COMPANY SNAPSHOT
TABLE 56.B. BRAUN.: OPERATING SEGMENTS
TABLE 57.B. BRAUN: PRODUCT PORTFOLIO
TABLE 58.BD: COMPANY SNAPSHOT
TABLE 59.BD: OPERATING SEGMENTS
TABLE 60.BD: PRODUCT PORTFOLIO
TABLE 61.CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 62.CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 63.CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 64.HENKE-SASS WOLF: COMPANY SNAPSHOT
TABLE 65.HENKE-SASS WOLF: OPERATING SEGMENTS
TABLE 66.HENKE-SASS WOLF: PRODUCT PORTFOLIO
TABLE 67.NIPRO: COMPANY SNAPSHOT
TABLE 68.NIPRO: OPERATING SEGMENTS
TABLE 69.NIPRO: PRODUCT PORTFOLIO:
TABLE 70.NOVO NORDISK: COMPANY SNAPSHOT
TABLE 71.NOVO NORDISK: OPERATING SEGMENTS
TABLE 72.NOVO NORDISK: PRODUCT PORTFOLIO
TABLE 73.RETRACTABLE TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 74.RETRACTABLE TECHNOLOGIES, INC.: OPERATING SEGMENTS
TABLE 75.RETRACTABLE TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
TABLE 76.TERUMO: COMPANY SNAPSHOT
TABLE 77.TERUMO CORPORATION: PRODUCT SEGMENTS
TABLE 78.TERUMO: PRODUCT PORTFOLIO
TABLE 79.VITA NEEDLE: COMPANY SNAPSHOT
TABLE 80.VITA NEEDLE: OPERATING SEGMENTS
TABLE 81.VITA NEEDLE: PRODUCT PORTFOLIO
TABLE 01.GLOBAL DISPOSABLE SYRINGES MARKET, BY PRODUCT TYPE, 2018-2026 ($MILLION )
TABLE 02.CONVENTIONAL DISPOSABLE SYRINGES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 03.SAFETY DISPOSABLE SYRINGES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 04.GLOBAL DISPOSABLE SYRINGES MARKET, BY APPLICATION, 2018-2026 ($MILLION )
TABLE 05.DISPOSABLE SYRINGES MARKET FOR IMMUNIZATION INJECTIONS, BY REGION, 2018–2026 ($MILLION)
TABLE 06.DISPOSABLE SYRINGES MARKET FOR THERAPEUTIC INJECTIONS, BY REGION, 2018–2026 ($MILLION)
TABLE 07.DISPOSABLE SYRINGES MARKET, BY REGION, 2018-2026 ($MILLION )
TABLE 08.NORTH AMERICA DISPOSABLE SYRINGES MARKET REVENUE, BY COUNTRY, 2019–2026 ($MILLION)
TABLE 09.U.S. DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 10.U.S. DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 11.CANADA DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 12.CANADA DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 13.MEXICO DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 14.MEXICO DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 15.NORTH AMERICA DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026($MILLION)
TABLE 16.NORTH AMERICA DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 17.EUROPE DISPOSABLE SYRINGES MARKET REVENUE, BY COUNTRY, 2019–2026 ($MILLION)
TABLE 18.GERMANY DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 19.GERMANY DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 20.FRANCE DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 21.FRANCE DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 22.UK DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 23.UK DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 24.ITALY DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 25.ITALY DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 26.REST OF EUROPE DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 27.REST OF EUROPE DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 28.EUROPE DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026($MILLION)
TABLE 29.EUROPE DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 30.ASIA-PACIFIC DISPOSABLE SYRINGES MARKET REVENUE, BY COUNTRY, 2019–2026 ($MILLION)
TABLE 31.JAPAN DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 32.JAPAN DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 33.CHINA DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 34.CHINA DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 35.INDIA DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 36.INDIA DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 37.REST OF ASIA-PACIFIC DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 38.REST OF ASIA-PACIFIC DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 39.ASIA-PACIFIC DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026($MILLION)
TABLE 40.ASIA-PACIFIC DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 41.LAMEA DISPOSABLE SYRINGES MARKET REVENUE, BY COUNTRY, 2019–2026 ($MILLION)
TABLE 42.BRAZIL DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 43.BRAZIL DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 44.SOUTH AFRICA DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 45.SOUTH AFRICA DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 46.SAUDI ARABIA DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 47.SAUDI ARABIA DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 48.REST OF LAMEA DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 49.REST OF LAMEA DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 50.LAMEA DISPOSABLE SYRINGES MARKET REVENUE, BY PRODUCT TYPE, 2019–2026($MILLION)
TABLE 51.LAMEA DISPOSABLE SYRINGES MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 52.BAXTER: COMPANY SNAPSHOT
TABLE 53.BAXTER: OPERATING SEGMENTS
TABLE 54.BAXTER: PRODUCT PORTFOLIO
TABLE 55.B. BRAUN.: COMPANY SNAPSHOT
TABLE 56.B. BRAUN.: OPERATING SEGMENTS
TABLE 57.B. BRAUN: PRODUCT PORTFOLIO
TABLE 58.BD: COMPANY SNAPSHOT
TABLE 59.BD: OPERATING SEGMENTS
TABLE 60.BD: PRODUCT PORTFOLIO
TABLE 61.CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 62.CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 63.CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 64.HENKE-SASS WOLF: COMPANY SNAPSHOT
TABLE 65.HENKE-SASS WOLF: OPERATING SEGMENTS
TABLE 66.HENKE-SASS WOLF: PRODUCT PORTFOLIO
TABLE 67.NIPRO: COMPANY SNAPSHOT
TABLE 68.NIPRO: OPERATING SEGMENTS
TABLE 69.NIPRO: PRODUCT PORTFOLIO:
TABLE 70.NOVO NORDISK: COMPANY SNAPSHOT
TABLE 71.NOVO NORDISK: OPERATING SEGMENTS
TABLE 72.NOVO NORDISK: PRODUCT PORTFOLIO
TABLE 73.RETRACTABLE TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 74.RETRACTABLE TECHNOLOGIES, INC.: OPERATING SEGMENTS
TABLE 75.RETRACTABLE TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
TABLE 76.TERUMO: COMPANY SNAPSHOT
TABLE 77.TERUMO CORPORATION: PRODUCT SEGMENTS
TABLE 78.TERUMO: PRODUCT PORTFOLIO
TABLE 79.VITA NEEDLE: COMPANY SNAPSHOT
TABLE 80.VITA NEEDLE: OPERATING SEGMENTS
TABLE 81.VITA NEEDLE: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.GLOBAL DISPOSABLE SYRINGES MARKET SEGMENTATION
FIGURE 02.TOP PLAYER POSITIONING, 2018
FIGURE 03.TOP INVESTMENT POCKETS
FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIER
FIGURE 05.LOW BARGAINING POWER OF BUYERS
FIGURE 06.LOW THREAT OF SUBSTITUTES
FIGURE 07.HIGH INTENSITY OF RIVALRY
FIGURE 08.LOW THREAT OF NEW ENTRANT
FIGURE 09.IMPACT ANALYSES, DISPOSABLE SYRINGES MARKET
FIGURE 10.COMPARATIVE SHARE ANALYSIS OF CONVENTIONAL DISPOSABLE SYRINGES MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11.COMPARATIVE SHARE ANALYSIS OF NASAL DISPOSABLE SYRINGES MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF DISPOSABLE SYRINGES MARKET FOR IMMUNIZATION INJECTIONS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DISPOSABLE SYRINGES MARKET FOR THERAPEUTIC INJECTIONS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14.U.S. DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 15.CANADA DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 16.MEXICO DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 17.GERMANY DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 18.FRANCE DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 19.UK DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 20.ITALY DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 21.REST OF EUROPE DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 22.JAPAN DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 23.CHINA DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 24.INDIA DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 25.REST OF ASIA-PACIFIC DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 26.BRAZIL DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 27.SOUTH AFRICA DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 28.SAUDI ARABIA DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 29.REST OF LAMEA DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 30.BAXTER: NET SALES, 2016–2018 ($MILLION)
FIGURE 31.BAXTER: REVENUE SHARE BY SEGMENT, 2018(%)
FIGURE 32.BAXTER: REVENUE SHARE BY REGION, 2018(%)
FIGURE 33.B. BRAUN: NET SALES, 2018–2019 ($MILLION)
FIGURE 34.BD: NET SALES, 2016–2018 ($MILLION)
FIGURE 35.BD: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 36.BD: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 37.CARDINAL HEALTH: NET SALES, 2016–2018 ($MILLION)
FIGURE 38.CARDINAL HEALTH: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 39.CARDINAL HEALTH: REVENUE SHARE BY REGION, 2018(%)
FIGURE 40.NIPRO: NET SALES, 2016–2018 ($MILLION)
FIGURE 41.NIPRO: REVENUE SHARE BY SEGMENTS, 2018(%)
FIGURE 42.NIPRO: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 43.NET SALES, 2016–2018 ($MILLION)
FIGURE 44.NOVO NORDISK: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 45.NOVO NORDISK: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 46.RETRACTABLE TECHNOLOGIES, INC.: NET SALES, 2016–2018 ($MILLION)
FIGURE 47.RETRACTABLE TECHNOLOGIES, INC.: REVENUE SHARE BY SEGMENTS, 2018(%)
FIGURE 48.RETRACTABLE TECHNOLOGIES, INC.: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 49.TERUMO: NET SALES, 2016–2018 ($MILLION)
FIGURE 50.TERUMO: REVENUE SHARE BY SEGMENTS, 2018 (%)
FIGURE 51.TERUMO: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 01.GLOBAL DISPOSABLE SYRINGES MARKET SEGMENTATION
FIGURE 02.TOP PLAYER POSITIONING, 2018
FIGURE 03.TOP INVESTMENT POCKETS
FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIER
FIGURE 05.LOW BARGAINING POWER OF BUYERS
FIGURE 06.LOW THREAT OF SUBSTITUTES
FIGURE 07.HIGH INTENSITY OF RIVALRY
FIGURE 08.LOW THREAT OF NEW ENTRANT
FIGURE 09.IMPACT ANALYSES, DISPOSABLE SYRINGES MARKET
FIGURE 10.COMPARATIVE SHARE ANALYSIS OF CONVENTIONAL DISPOSABLE SYRINGES MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11.COMPARATIVE SHARE ANALYSIS OF NASAL DISPOSABLE SYRINGES MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF DISPOSABLE SYRINGES MARKET FOR IMMUNIZATION INJECTIONS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DISPOSABLE SYRINGES MARKET FOR THERAPEUTIC INJECTIONS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14.U.S. DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 15.CANADA DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 16.MEXICO DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 17.GERMANY DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 18.FRANCE DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 19.UK DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 20.ITALY DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 21.REST OF EUROPE DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 22.JAPAN DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 23.CHINA DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 24.INDIA DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 25.REST OF ASIA-PACIFIC DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 26.BRAZIL DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 27.SOUTH AFRICA DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 28.SAUDI ARABIA DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 29.REST OF LAMEA DISPOSABLE SYRINGES MARKET, 2018-2026 ($MILLION)
FIGURE 30.BAXTER: NET SALES, 2016–2018 ($MILLION)
FIGURE 31.BAXTER: REVENUE SHARE BY SEGMENT, 2018(%)
FIGURE 32.BAXTER: REVENUE SHARE BY REGION, 2018(%)
FIGURE 33.B. BRAUN: NET SALES, 2018–2019 ($MILLION)
FIGURE 34.BD: NET SALES, 2016–2018 ($MILLION)
FIGURE 35.BD: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 36.BD: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 37.CARDINAL HEALTH: NET SALES, 2016–2018 ($MILLION)
FIGURE 38.CARDINAL HEALTH: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 39.CARDINAL HEALTH: REVENUE SHARE BY REGION, 2018(%)
FIGURE 40.NIPRO: NET SALES, 2016–2018 ($MILLION)
FIGURE 41.NIPRO: REVENUE SHARE BY SEGMENTS, 2018(%)
FIGURE 42.NIPRO: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 43.NET SALES, 2016–2018 ($MILLION)
FIGURE 44.NOVO NORDISK: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 45.NOVO NORDISK: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 46.RETRACTABLE TECHNOLOGIES, INC.: NET SALES, 2016–2018 ($MILLION)
FIGURE 47.RETRACTABLE TECHNOLOGIES, INC.: REVENUE SHARE BY SEGMENTS, 2018(%)
FIGURE 48.RETRACTABLE TECHNOLOGIES, INC.: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 49.TERUMO: NET SALES, 2016–2018 ($MILLION)
FIGURE 50.TERUMO: REVENUE SHARE BY SEGMENTS, 2018 (%)
FIGURE 51.TERUMO: REVENUE SHARE BY REGION, 2018 (%)
